Avastin Questionable as a Breast Cancer Drug

In considering whether to allow Genentech to market Avastin as a breast cancer drug, the FDA is now saying that the drug has not proven to prolong the lives of those with advanced breast cancer. Furthermore, Avastin carries with it some serious side effects including cardiovascular problems, bowel perforations, and possible death. Avastin was approved by the FDA to treat colon cancer in 2004.